RxAnte and Mosaic Pharmacy Service Co-Present: Caring for Medically Complex and Vulnerable Members

On May 28 in conjunction with the PQA 2020 Annual Meeting, RxAnte and Mosaic Pharmacy Service presented an Innovation Theater focused on the role of a comprehensive pharmacy service in addressing the needs of medically complex and vulnerable Medicare members. Listen to our 20-minute session hosted by Sapna Patel, RPh, Clinical Director of Mosaic Pharmacy Service, to understand the process behind implementing this level of pharmacy service, and discover the real-world impact that Mosaic has made in optimizing for medication cost, quality, and safety for this vulnerable segment of Medicare populations.

Interested in learning more about Mosaic Pharmacy Service and how we can help you achieve your pharmacy quality goals? Contact us today.

Related Resources

6.29.22

by Patricia Powers, PharmD

How Mosaic’s Comprehensive Pharmacy Support Enables Better Care at Home

As the Director of Clinical Services at Mosaic Pharmacy Service, Patricia Powers, Pharm.D. is responsible for overseeing the development and delivery of clinical services for all Mosaic members, RxAnte’s high-touch pharmacy service. This month we asked Dr. Powers to share her insights around at-home care coordination benefiting both the patient and the health system and how Mosaic’s comprehensive pharmacy support can help enable better care at home.

5.25.22

by Tori Erxleben Rush, PharmD

CMS Announcement for Medicare Advantage Part C and D plans

In early April, the Center for Medicaid and Medicare Services shared its Announcement for Medicare Advantage Part C and D plans, incorporating feedback solicited after an Advance Notice was issued in February 2022. Overall, not much has changed since the Advance Notice, however CMS addressed the comments issued by Medicare Advantage stakeholders like MA organizations and prescription drug plan sponsors.

4.4.22

The need for value-based pharmacy services

There is a strong push among physicians to transition to care models that incentivize fewer, more effective treatments. This same perspective should also be held in pharmacy. As we look to a post-pandemic healthcare system, improvements need to be made to remedy these concerns with focuses on barriers to optimal quality and cost--particularly for the medically complex and socially vulnerable.